PHARMACEUTICAL COMPOSITION FOR COMBINATION THERAPY CONTAINING BISPECIFIC ANTI-C-MET/ANTI-FGFR ANTIBODY AND C-SRC INHIBITOR

摘要

Provided is a pharmaceutical composition for a combination therapy for treating and/or preventing cancer, containing a bispecific anti-c-Met/anti-EGFR antibody and a c-Src inhibitor.